Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1051 | 956 | 1051 | 1074 | 1332 | 1717 |
Fund Return | 5.15% | -4.43% | 5.15% | 2.41% | 5.91% | 5.56% |
Place in category | 1481 | 1661 | 1481 | 931 | 717 | 528 |
% in Category | 73 | 80 | 73 | 55 | 47 | 54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global SmartBeta Equity ZI Capitale | 1.96B | 23.90 | 8.22 | 11.51 | ||
LU1774149998 | 1.88B | 23.46 | 7.83 | 11.11 | ||
LU1536921650 | 1.02B | 19.31 | -0.37 | - | ||
Global Optimal Income F Distributio | 650.45M | 12.12 | -0.39 | 3.89 | ||
Global Optimal Income A Capitalisat | 650.45M | 11.45 | -0.98 | 3.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 163M | 15.77 | 4.40 | 5.61 | ||
European Growth Fund E Acc EUR | 21.08M | 14.87 | 3.61 | 4.82 | ||
European Growth Fund Y Acc EUR | 257.93M | 16.70 | 5.28 | 6.49 | ||
European Growth Fund Y DIST EUR | 65.77M | 16.70 | 5.28 | 6.49 | ||
European Growth Fund A DIST Eue | 6.7B | 15.73 | 4.38 | 5.61 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.06 | 748.10 | +2.14% | |
AstraZeneca | GB0009895292 | 4.78 | 11,040.0 | -0.11% | |
Allianz | DE0008404005 | 4.39 | 306.50 | 0.00% | |
Ashtead Group | GB0000536739 | 3.70 | 5,434.0 | -0.59% | |
Novo Nordisk B | DK0062498333 | 3.11 | 581.6 | +1.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review